Pneumonia continues to be a leading cause of hospitalization and mortality. Implementation of health information technology (HIT) can lead to cost savings and improved care. In this review, we examine the literature on the use of HIT in the management of community-acquired pneumonia. We also discuss barriers to adoption of technology in managing pneumonia, the reliability and quality of electronic health data in pneumonia research, how technology has assisted pneumonia diagnosis and outcomes research. The goal of using HIT is to develop and deploy generalizable, real-time, computerized clinical decision support integrated into usual pneumonia care. A friendly user interface that does not disrupt efficiency and demonstrates improved clinical outcomes should result in widespread adoption.
INTRODUCTION
In the new millennium, more healthcare systems around the world are integrating health information technology (HIT) into their care of patients. Technology will hopefully lead to improvements in the delivery of healthcare and patient outcomes. In 2005, the RAND Corporation analysed the potential benefits of widespread implementation of HIT in the United States and concluded that it could save billions of dollars annually. 1 In 2011, it was estimated that 84% of emergency departments (ED) and 73% of outpatient departments in the United States have adopted electronic health record (EHR) systems. 2 Data suggest that HIT adoption can lead to safer, more effective and more efficient care; however, results in many areas of HIT remain inconclusive. [3] [4] [5] [6] [7] HIT is a diverse set of technologies for transmitting and managing health information for use by providers, patients, insurers and administrators. Great variability in usability and functionality exists in available HIT systems; however, basic functionalities common to most systems include 6, 8 : 1. EHR allowing for health data storage, organization, delivery and results management.
Computerized physician order entry (CPOE). 3. Computerized clinical decision support (CCDS).
The advancement of HIT provides an opportunity to improve management of a variety of diseases including community-acquired pneumonia, a leading cause of hospitalization and death in the United States. Costs of managing pneumonia surpassed $10 billion dollars annually in 2011; the cost of inpatient care is 25 times that of outpatient care. 9 Guidelines and severity assessment tools help in managing patients with pneumonia. Adherence to guidelines has been shown to improve outcomes in pneumonia. 10, 11 Despite this, clinicians vary greatly in the management of pneumonia patients. 12 Using HIT effectively in patients with pneumonia may improve adherence to guidelines and improve patient outcomes. The present review article describes how HIT has been used in the management of community-acquired pneumonia and gives recommendations for future study and use.
REVIEW METHODS
We built upon our previous review on this topic published in 2012 and conducted an electronic search using PubMed. 13 Our search terms were: (i) clinical decision support and community-acquired pneumonia, (ii) community-acquired pneumonia and technology, (iii) electronic clinical decision support and pneumonia, (iv) personal digital assistant and pneumonia, (v) computerized physician order entry and pneumonia and (vi) pneumonia and technology implementation.
After initial results, we only included articles that investigated the use of HIT in improving care and outcomes in community-acquired pneumonia. We excluded articles discussing ventilator or hospitalacquired pneumonia or paper-based decision support methods. From these articles, we also reviewed the bibliographies for additional qualifying articles not found by our search terms.
RESULTS
Our PubMed search yielded 309 articles, 29 of which were relevant to the present review. An additional 13 articles were obtained from bibliographic review. We excluded seven due to lack of impactful findings. Several articles are primary research performed by our group, new since our last review on this topic. Only one article studied the effect of technology to influence major outcomes such as mortality. 14 The majority of articles focused on the use of technology in aiding adherence to pneumonia-specific guidelines or the Centers for Medicare and Medicaid Services (CMS) core measures. Many articles identified barriers leading to low utilization by clinicians. We present these results organized into the following categories:
• The influence of technology on quality of care and guideline compliance in pneumonia • Barriers influencing a clinician's decision to use technology in managing pneumonia • Reliability and quality of pneumonia data obtained from EHR • Technology aiding in the diagnosis of pneumonia • Research studying impact on pneumonia outcomes
The influence of technology on quality of care and guideline compliance in pneumonia Compliance with CMS core measures and guidelines Process-of-care measures for pneumonia promoted by CMS are thought to be indicative of quality of care and may lead to improved outcomes. Several studies evaluated HIT to improve compliance with these measures but the results are mixed.
In 2012, Sikka et al. studied the impact of an automated dispensing cabinet alert on improving compliance with the core measure of obtaining blood cultures prior to giving antibiotics to patients with pneumonia being admitted to the hospital. Compliance with this measure increased from 84% in the pre-intervention period to 95% in the post-intervention period (P < 0.001). 15 In a study by Ostrowsky et al., an antibiotic stewardship team developed a communityacquired pneumonia treatment algorithm with the goal of improving guideline compliance. Although the algorithm was posted on paper, they developed a pneumonia treatment kit containing guidelinecompliant antibiotic regimens to be dispersed by an automated dispensing cabinet. The automated cabinet facilitated correct antibiotic type and dosing and allowed the research team to track its use. Appropriate antibiotic use in community-acquired pneumonia in two ED increased from 55% to 93% (P < 0.001) and from 64% to 91% (P = 0.004), respectively. 16 These studies show that automated pharmacy technology may improve guideline compliance and aid in data collection.
In 2010, Jones et al. examined whether implementing a new EHR or upgrading an existing system would improve care. They used the Health Information and Management Systems Society (HIMSS) large database of over 3900 US acute care hospitals and studied quality indicators for pneumonia, heart failure and acute myocardial infarction. For pneumonia, they did not find any consistent improvement over time in quality indictors regardless of EHR adoption or upgrade. 17 A similar study by Himmelstein et al. studied whether the level of computerization in hospitals affected quality of care and costs. They used the HIMSS database in addition to Medicare Cost Reports and the 2008 Dartmouth Health Atlas for data analysis. They found that higher computerization scores did not correlate with better quality of pneumonia care, nor did it reduce administrative or overall costs. 18 Other studies looking at compliance with CMS core measures have had mixed results. Filardo et al. performed a randomized controlled trial of a web-based educational quality benchmarking and case review tool among rural hospitals in Texas. The outcome was CMS pneumonia core indicator compliance. The study saw no improvement between study groups, even when excluding hospitals that did not complete the training. 19, 20 Weiner et al., in a before and after intervention trial, implemented an 'audit and feedback' policy utilizing weekly performance emails to providers in an attempt to improve the quality measure of giving antibiotics within 4 h of pneumonia presentation. They showed a small decrease in time to first dose of antibiotics from 162 to 146 min and an increase in overall compliance with the quality measure from 77.5% to 86.1%. 21 
Computerized clinical decision support
In 2002, Flanagan et al. looked at email prompts to physicians reminding them to use an available CCDS for pneumonia. 22 The study was plagued with poor compliance. The initial email was ignored 50% of the time and the severity tool was used one-third of the time. This suggests that email-based prompts have poor receiver compliance.
An Australian study by Buising et al. questioned whether CCDS could improve adherence to antibiotic guidelines for community-acquired pneumonia. 23 They collected data over three time periods including a baseline practice period, an academic detailing period in which a team educated clinicians about prescribing guidelines and a third period in which the CCDS was implemented. The tool used national pneumonia guidelines to assist clinicians in ED disposition and management of the patients. With each successive time period, they were able to demonstrate improved antibiotic guideline compliance (OR = 2.79 (1.88, 4.14) for period 1 to 2, and OR = 1.99 (1.07, 3.69) for period 2 to 3). This improvement with CCDS implementation was greater than that expected to have occurred with time and academic detailing alone, based on predictions from a binary logistic model. The sustainability of this effect was not studied.
Does CCDS help in rural locations? Mitchell et al. examined the association between CCDS use and quality disparities in pneumonia process indicators between rural and urban hospitals. 24 Their composite database included 2405 urban and rural hospitals. Quality scores for pneumonia were lower in rural hospitals. After controlling for CCDS use, the propensity for CCDS use and hospital and community characteristics, this quality difference was no longer statistically different. Mitchell et al.'s group later showed that areas with high minority populations had lower pneumonia quality composite scores as compared to low minority populations; however, this effect was abolished after correcting for propensity to use CCDS. 25 These results suggest that EHR and CCDS adoption may improve the quality of pneumonia care in underserved areas.
Stevenson et al. studied an internet-based CCDS system for community-acquired pneumonia in five rural hospitals in southwestern Idaho. 26 Each hospital developed an antimicrobial management team (AMT) responsible for identifying pneumonia patients and entering clinical information into the CCDS tool. The team would then relay the recommendations to the treating physician. The AMT was developed due to physician perception that it would take too much time to utilize the tool themselves. Despite the AMT, there was poor compliance with the implemented protocols. The AMT in three of five hospitals failed to communicate the recommendations at all. The other two hospitals had recommendations relayed 71% and 32% of the time, but those recommendations were followed 24% and 50% of the times they were relayed.
Computerized physician order entry
The effects of CPOE in improving pneumonia care have also been studied. Kawahara and Jordan successfully employed an alert in the CPOE to use a less expensive antibiotic, cefonicid, when treating pneumonia. 27 The use of more costly cefuroxime decreased from 100% to 22% and the average acquisition cost of antibiotics per patient decreased from $123 to $48.
Appari et al. used a large database to study whether CPOE and electronic medication administration records (eMAR) improved adherence to antibiotic treatment guidelines (antibiotic given within 6 h and appropriate initial antibiotic given) for patients hospitalized with pneumonia. 28 The use of both CPOE and eMAR were associated with greater compliance with these core measures (adjusted OR = 1.19 (1.04-1. 35 ) and adjusted OR = 1.25 (1.14-1.38), respectively).
Westphal et al. conducted a pre-and postintervention study evaluating physician guideline adherence after incorporating antibiotic guidelines for pneumonia into the CPOE at a single mental health hospital in France. 29 Physicians received alerts while placing orders, in addition to educational reinforcement. They noted significant improvement in pneumonia guideline-recommended antibiotic dosing (88% vs 73%) and duration (93% vs 82%), but not in choice of antibiotic (82% vs 75%, P = 0.12). 30 Ninety-one percent of participating clinicians said they would consider using a tool for pneumonia. They preferred a tool that had high sensitivity for predicting mortality or the likelihood of return to the emergency room within the next 14 days.
Barriers influencing
Tool complexity and efficiency are barriers to CCDS use. In response to the increasing complexity in some electronic order sets, Shine et al. studied the accuracy of clinician responses to question prompts embedded in electronic admission and discharge order sets. 31 Seventy-five percent of clinicians endorsed intentionally responding inaccurately to irrelevant questions. Physicians would frequently ignore order sets due to their complexity, feeling they were time-consuming and for documentation purposes only.
Age and clinical experience may be associated with less employment of CCDS. McCullagh et al. published a study looking at CCDS use across different provider training levels. 32 The intervention arm had access to a CCDS tool during pneumonia and strep pharyngitis visits. The tool utilized the Walsh rule for strep pharyngitis and the Heckerling rule for pneumonia. 33 The EHR system recorded acceptance of the CCDS alert, completion of the risk score calculators and signing of medical order sets. Attending physicians used CCDS less than post-graduate year 1 trainees (23% vs 80% acceptance, P = 0.02). Attending physicians tended to use the order sets less frequently and order more antibiotics than lower level trainees.
Automation and efficiency of the technology may play a role in adoption. Niemi et al. studied the ability of an automated system to identify pneumonia and heart failure patients early enough to allow time for intervention if core CMS performance measures were not being met. 34 The tool collected various data points from the EHR to calculate the probability of pneumonia. After identifying patients, the system determined whether the appropriate antibiotics had been ordered and verified pneumococcal vaccine status, and notified clinicians. The sensitivity and specificity of the tool for detecting pneumonia at 3 h were 89% and 86%, respectively. These improved to 92% and 90% at 20 h from presentation. Despite the tool's automation and accuracy, compliance with these pneumonia core measures did not increase significantly.
Reliability and quality of pneumonia data obtained from EHR
Some studies focused on methodology used to select study populations for pneumonia research within an EHR. Administrative databases record claims-based definitions, such as International Classification of Diseases (ICD) codes and Diagnostic-Related Group (DRG) codes. Aronsky et al. compared the accuracy of five claims-based pneumonia definitions with an independent, clinical pneumonia reference standard. 35 They also examined whether severity of disease, hospital admission rates, length of stay, mortality and costs were influenced by these claims-based pneumonia identification strategies. The sensitivity of claims-based algorithms ranged from 47.8% to 66.2% and positive predictive values ranged from 72.6% to 80.8%. They concluded that claims-based pneumonia identifiers are imprecise; especially DRG codes. Whittle et al. similarly concluded that DRG codes were less precise than ICD codes in selecting a community-acquired pneumonia population, and underestimate hospital length of stay. 36 To improve accuracy of identifying communityacquired pneumonia patients, Yu et al. searched for additional information beyond ICD-9 codes. 37 They identified patients by ICD-9 code and looked for evidence of true pneumonia by chart review. Using classification and regression tree analysis, adding length of stay improved classification of pneumonia cases. Their algorithms had higher sensitivity (81-98%) and positive predictive values (82-84%) with modest decreases in specificities (48-82%). Our group has demonstrated improved detection of pneumonia patients through review of chest imaging reports after ICD-9 code identification with a sensitivity of 68% and specificity of 99% compared to expert case review. 14 Hripcsak et al. significantly described the addition of bias by using large electronic datasets for research purposes. 38 The challenges include data inaccuracy, incompleteness and complexity compared to traditional manual chart review, demonstrated using a pneumonia cohort. They suggested processes to verify data accuracy, including constraints to narrow the cohort to a more representative population, and manual chart review for the extremes of the population as these have greater effects on results.
Aronsky and Haug assessed the quality of clinical data in an EHR for calculating the pneumonia severity index, which had been previously derived using manual extraction from paper charts. 39 They compared this extraction to their own manual extraction from the paper chart. They found that the risk class was identical in 87% of patients and concordance averaged 0.98 when all patient variables were taken into account. This suggested the EHR can be effectively used for risk score calculation and for CCDS to aid in admission decisions.
Jones et al. took it one step further and developed an electronic version of CURB-65 (confusion, uraemia, respiratory rate, blood pressure, age > 65), called eCURB, that uses continuous and weighted elements rather than the traditional binary elements. 40 The tool was validated in local and international cohorts, demonstrating more accurate 30-day mortality prediction than CURB-65. eCURB could be incorporated into an electronic CCDS tool to aid triage decisions.
Technology aiding in the diagnosis of pneumonia
Morillo et al. used a novel approach to diagnose pneumonia in patients with chronic obstructive pulmonary disease (COPD). 41 They recorded suprasternal respiratory sounds via auscultation of COPD patients with and without pneumonia. They performed computerized analysis of the extracted features from the recorded sounds to develop a model to predict the presence of pneumonia in COPD patients with sensitivity and specificity of 72% and 82%, respectively. Characteristics from recorded respiratory sounds may aid pneumonia diagnosis and may be particularly useful in locations without available radiology and in telemedicine.
Dean built on Aronsky's earlier work to develop an electronic screening tool to aid ED physicians in diagnosing pneumonia. 42 ePneumonia is a CCDS tool that helps providers identify ED patients with pneumonia and recommends evidence-based management. It pulls data including vital signs, laboratory values, chest radiograph findings and a patient's prior history from the EHR in real time and assesses the likelihood of pneumonia. The treating clinician then receives an alert in the EHR when the likelihood of pneumonia exceeds 40%. The clinician is prompted to confirm or reject the diagnosis of pneumonia. The tool then generates orders and antibiotic recommendations based on the Infectious Disease Society of American/American Thoracic Society 2007 guidelines, mortality-risk assessment using eCURB (described in a previous section) and disposition recommendation based on pneumonia severity. 43 Dean et al. demonstrated that ePneumonia alerted in 81 of 109 (74%) true cases of pneumonia (defined by physician review). 44 The tool falsely alerted in 78 of 612 patients without pneumonia (13%). Sensitivity was 41% (95% CI: 32-52%) and specificity 96.6% (95% CI: 95.9-97.3%). False negatives were most commonly due to lack of clinical pneumonia features apart from chest imaging. ePneumonia aids diagnosis of pneumonia by using a Bayesian network to predict the likelihood of pneumonia based on common values found in the EHR. ePneumonia runs automatically using routinely available data elements from the EHR, and does not require manual data entry. Aronsky and Haug had earlier described this method for electronic, real-time pneumonia diagnosis. 42, 45, 46 ePneumonia uses natural language processing to extract pneumonia-related findings from chest imaging reports. This method was first described by Fiszman et al. 47 Performance of natural language processing was similar to that of physicians and better than lay persons and keyword searches. Implementing this technology into a CCDS tool aids in pneumonia diagnosis.
Research studying impact on pneumonia outcomes
In 2015, Dean et al. published the results of a prospective quasi-experimental controlled trial of ePneumonia implementation.
14 They compared 30-day mortality pre-and post-deployment in four hospitals with three hospitals as concurrent controls. There was no significant difference in overall severity-adjusted mortality using ePneumonia (OR = 0.69; 95% CI: 0.41-1.16). Post hoc analysis showed significantly lower mortality among patients with community-acquired pneumonia (OR = 0.53; 95% CI: 0.28-0.99), but not healthcareassociated pneumonia. Length of stay and overall admission rates did not differ between study groups.
DISCUSSION
The majority of available literature remains focused on using technology to improve compliance with pneumonia guidelines and CMS core measures. Several articles point to difficulties integrating technology for pneumonia management. Our group demonstrated steps forward in CCDS tool design and application, although confirmation of improved outcomes is needed. Much work remains to show that HIT can improve outcomes in pneumonia patients and results are not yet compelling enough to recommend implementation in all emergency departments. 48 Each study using CCDS and CPOE to improve guideline and CMS core measure compliance presented different methods of implementation with varying levels of success. Success often depended on the level of clinician engagement with the intervention. Automated pharmacy technology, from simple alert interventions to assuring appropriate antibiotic choice and dosing and data collection, provides a useful avenue to improve guideline compliance. We saw good results when email was used to show provider guideline performance but poor results when used as a reminder to use CCDS tools. Studies using large databases such as HIMSS which includes~90% of hospitals in the United States failed to show significant improvements in core measure compliance with the adoption of EHR. Mitchell et al. showed that CCDS might improve outcomes in rural and underserved populations, although the results are not conclusive. Several studies showed improved compliance with guidelines and core measures using CPOE, a promising tool for future study.
The inconsistent results from these studies are due to small sample sizes in some studies, and wide variation in type and complexity of the technology intervention. Many studies identified common barriers to technology implementation for managing pneumonia. Aside from the financial, liability, education and training barriers common to most HIT systems, we identified barriers specific to clinicians. These include usability, complexity, efficiency and accuracy of the CCDS or CPOE, as well as the age, level of training and attitudes of the clinicians. No intervention was immune to these barriers and some were unsuccessful because of them.
We also examined the accuracy of databases and search criteria for pneumonia research. Databases that only use claims-based pneumonia data suffer from data inaccuracy, incompleteness and complexity. This can be countered by including additional search criteria to focus the research population and performing random manual chart review to confirm accurate data. More rigorously developed pneumonia databases provide relatively accurate data for risk score development and validation.
Considerable research and development in CCDS comes from our group with ePneumonia, built upon prior work. Common barriers addressed when designing ePneumonia included automation, real-time electronic alerts, reasonable accuracy for pneumonia diagnosis and efficient severity, triage and treatment rules. This is the only study that looked at mortality outcomes post implementation, although overall mortality was not reduced. Post hoc analysis did demonstrate a mortality benefit in community-acquired pneumonia, paving the way for future study to confirm these results.
Editorials published by Gellad et al. and Landman identified future directions for CCDS tool development and implementation. 48, 49 A tool must be usable, with accuracy exceeding physician judgement alone, and lead to improvement in quality of care, outcomes or costs of care. A tool must achieve high levels of adoption by clinicians and require minimal manual input. A tool should provide high specificity over sensitivity, to avoid a high false-positive rate and the ensuing 'alert fatigue' that leads to decreased tool use by clinicians.
We think an ideal tool should augment rather than replace physician decision-making. It should be easy to use, not disrupt work flow and translate its recommendations into orders. It should also have safeguards to prevent antibiotic dosing errors and provide drugallergy verification. Ultimately, we believe a high performing CCDS tool will lead to improved care and patient outcomes.
HIT has come a long way. We are in the age when technological advancement can assist clinicians in screening and improving care for patients with pneumonia. Further research and development are needed, but we look forward with optimism.
